Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-07

Clinical Trial Update: Escalated Application of Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating escalated application of mesenchymal stem cells in amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Hospital e Maternidade Dr. Christóvão da Gama | Conditions: Motor Neuron Disease | Phase 1 | Status: COMPLETED